Nano-X Imaging Ltd.

NasdaqGM NNOX

Nano-X Imaging Ltd. Price to Book Ratio (P/B) on December 30, 2024: 2.45

Nano-X Imaging Ltd. Price to Book Ratio (P/B) is 2.45 on December 30, 2024, a 53.05% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Nano-X Imaging Ltd. 52-week high Price to Book Ratio (P/B) is 3.74 on February 16, 2024, which is 53.01% above the current Price to Book Ratio (P/B).
  • Nano-X Imaging Ltd. 52-week low Price to Book Ratio (P/B) is 1.54 on February 05, 2024, which is -37.14% below the current Price to Book Ratio (P/B).
  • Nano-X Imaging Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 2.32.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
NasdaqGM: NNOX

Nano-X Imaging Ltd.

CEO Mr. Erez I. Meltzer
IPO Date Aug. 21, 2020
Location Israel
Headquarters Communications Center
Employees 164
Sector Health Care
Industries
Description

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.

Similar companies

PACB

Pacific Biosciences of California, Inc.

USD 1.85

-7.96%

MGRM

Monogram Orthopaedics, Inc.

USD 2.47

0.82%

DXCM

DexCom, Inc.

USD 79.17

-0.84%

EW

Edwards Lifesciences Corporation

USD 71.04

-0.07%

SYK

Stryker Corporation

USD 362.80

0.50%

ABT

Abbott Laboratories

USD 113.02

-0.15%

MDT

Medtronic plc

USD 85.25

4.23%

MASS

908 Devices Inc.

USD 1.98

-1.49%

IART

Integra LifeSciences Holdings Corporation

USD 21.93

-1.62%

BSX

Boston Scientific Corporation

USD 95.65

1.10%

NVCR

NovoCure Limited

USD 26.23

-4.20%

ALGN

Align Technology, Inc.

USD 210.46

-1.51%

StockViz Staff

January 15, 2025

Any question? Send us an email